Skip to main content

Table 5 Comparison of NGAL and PCT at initial and follow-up measurements according to the in-hospital mortality

From: Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis

 

Survivors (n = 96)

Non-survivors (n = 13)

Initial measurement (mean ± SD)

Follow-up measurement (mean ± SD)

Initial measurement (mean ± SD)

Follow-up measurement (mean ± SD)

NGAL (ng/mL)

214.5 ± 249.1

148.7 ± 173.3*

727.4 ± 554.5

775.7 ± 562.1

PCT (ng/mL)

5.56 ± 15.4

0.61 ± 2.18

31.8 ± 72.6

18.4 ± 37.4

  1. * P < 0.0001 vs. initial measurement.
  2. P = 0.0012 vs. initial measurement.
  3. Both initial and follow-up data were available in 109 patients (96 survivors and 13 non-survivors).
  4. NGAL: neutrophil gelatinase-associated lipocalin; PCT: procalcitonin; SD: standard deviation.